Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Therapy cessation? 110 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Therapy cessation have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.2% of all adverse event reports for ESOMEPRAZOLE.

110
Reports of Therapy cessation with ESOMEPRAZOLE
0.2%
of all ESOMEPRAZOLE reports
4
Deaths
25
Hospitalizations

How Dangerous Is Therapy cessation From ESOMEPRAZOLE?

Of the 110 reports, 4 (3.6%) resulted in death, 25 (22.7%) required hospitalization, and 5 (4.5%) were considered life-threatening.

Is Therapy cessation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 110 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Therapy cessation?

DALFAMPRIDINE (4,580) ETANERCEPT (2,031) ADALIMUMAB (1,712) ABIRATERONE (1,602) VOXELOTOR (1,038) CLOZAPINE (885) LOMITAPIDE (828) CAPECITABINE (746) TREPROSTINIL (743) ISOTRETINOIN (633)

Which ESOMEPRAZOLE Alternatives Have Lower Therapy cessation Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Therapy cessation Reports All Drugs Causing Therapy cessation ESOMEPRAZOLE Demographics